We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA to Meet Roadmap Goals Through Adaptive Licensing, Other Initiatives
EMA to Meet Roadmap Goals Through Adaptive Licensing, Other Initiatives
July 11, 2011
The European Medicines Agency (EMA) is considering three new regulatory initiatives to improve drug safety and access, including adaptive licensing — authorizing drugs sooner but with greater initial limitations.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor